Kestra Medical Technologies, Ltd. (NASDAQ: KMTS) reported Q1 EPS of ($0.61), $0.19 worse than the analyst estimate of ($0.42). Revenue for the quarter came in at $24.6 million, versus $0 reported last year.

GUIDANCE:

Kestra Medical Technologies, Ltd. sees FY2026 revenue of $93 million, versus the consensus of $90.936 million.

For earnings history and earnings-related data on Kestra Medical Technologies, Ltd. (KMTS) click here.